NAME:	pENTR/D-TOPO 
RESISTANT MARKER:	Kanamycin resistant; 25 µg/ml
SOURCE:	Invitrogen Life Technologies
V_TYPE: 	Gateway entry vector
SEQUENCING PRIMERS: 	M13(-21), M13 reverse, T7
POLYLINKER SEQUENCE: 
taacgctagcatggatgttttcccagtcacgacgttgtaaaacgacggcc
agtcttaagctcgggccccaaataatgattttattttgactgatagtgac
ctgttcgttgcaacaaattgatgagcaatgcttttttataatgccaactt
tgtacaaaaaagcaggctccgcggccgcccccttcacc-ORF-aagggtg
ggcgcgccgacccagctttcttgtacaaagttggcattataagaaagcat
tgcttatcaatttgttgcaacgaacaggtcactatcagtcaaaataaaat
cattatttgccatccagctgatatcccctatagtgagtcgtattacatgg
tcatagctgtttcctggcagctctg

Note the specific antibiotic to be used with this vector.
Confirm sequencing primer sequences match vector before sequencing.
Visit the homepage of Invitrogen for more information on this vector.

All ORF clones are provided in Entry Vectors for the Invitrogen Gateway® 
cloning system. Invitrogen offers a whole range of Destination Vectors for 
a wide range of applications. Refer to the homepage of Invitrogen for further 
information on the GatewayR cloning system and related Invitrogen products at:
<a href="http://www.invitrogen.com/content.cfm?pageid=4072">http://www.invitrogen.com/content.cfm?pageid=4072</a>
For further information on the ORFeome Collaboration, visit their homepage at 
<a href="http://www.orfeomecollaboration.org/html/index.shtml">http://www.orfeomecollaboration.org/html/index.shtml</a>.
For further technical information visit our homepage at: <a href="http://www.dnaform.jp">http://www.dnaform.jp</a> 
or contact us under: <a href="mailto:techinfo@dnaform.jp">techinfo@dnaform.jp</a>.